Our vision is to become the most efficient and dynamic Pharmaceutical Regional Company proving Orphan Drugs or Niche Specialty Pharmaceuticals to fulfill the needs of needs of a small population of adults and children seeking life-preserving therapeutics for rare diseases.
International Symposium for the Management of Inborn Error of Metabolism (November 12th)
The Symposium was held at the Dolmen Hotel, city of Buenos Aires. International speakers from USA, Europe and Latin-America gave lectures about IEM.... 2016
VII Chilean Neonatology Congress (October 4-7th)
The launch of the Pedea (ibuprofen) for the treatment of patent ductus arteriosum was simultaneous to the Seventh Neonatology Congress.... 2016
56th Annual Chilean Congress of Pediatrics (October 5-8th)
Innovative Medicines was present, supporting continuous medical education.... 2016